Core Viewpoint - The stock of Peijia Medical-B (02565) has risen over 6%, reflecting positive market sentiment following the announcement of an extension of the lock-up period for cornerstone investors [1] Group 1: Stock Performance - Peijia Medical-B's stock price increased by 5.94%, reaching HKD 65.95, with a trading volume of HKD 5.0822 million [1] Group 2: Lock-up Period Announcement - The original end date of the lock-up period has been extended to December 31, 2025, following a previous extension [1] - As of the announcement date, cornerstone investors hold a total of 9.5845 million H-shares, representing approximately 3.43% of the company's total issued H-shares [1] Group 3: Investor Confidence - Cornerstone investors have agreed not to reduce their holdings of H-shares from the end of the original lock-up period until April 30, 2026, indicating their confidence in the company's future prospects [1] - The company believes that the second extension of the lock-up period reflects the cornerstone investors' confidence in its technological development and significant progress in major clinical milestones [1] - Cornerstone investors will continue to review the company's performance and may consider further extending the lock-up period based on real-time developments and achieved milestones [1]
港股异动 | 派格生物医药-B(02565)涨超6% 近日接获基石投资者自愿延长禁售期通知